Malignant ascitic fluid
Malignant ascitic fluid has been studied in 1 paper since 2016: none in people yet, 1 in cells. No study of it in people or animals has been published yet. The newest paper, Jul 21, 2016: “Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells”.
1 paper studies it1 findingUpdated
- 1 lab in 1 country
- Funder: Narodowe Centrum Nauki
- Cells1
What did studies of Malignant ascitic fluid find?
1Studies of Malignant ascitic fluid measured 1 outcome; the most studied are cellular senescence (1 study).
Cellular senescence
upin human cells1
1 study
Cellular senescence
upin human cells1
Malignant ascitic fluid induces cellular senescence in human cells.
“HPMCs, when exposed to malignant ascitic fluids, exhibited decreased proliferation and increased senescence rates.”
Cellsperitoneum
Cellular oncology (Dordrecht, Netherlands)
Latest
Cellular Oncology
Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells
Experiments in human cellsCellular senescence